+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Antimicrobial Susceptibility Testing - Global Strategic Business Report

  • PDF Icon

    Report

  • 382 Pages
  • December 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4805105
The global market for Antimicrobial Susceptibility Testing is estimated at US$3.6 Billion in 2023 and is projected to reach US$4.6 Billion by 2030, growing at a CAGR of 3.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the antimicrobial susceptibility testing market is driven by several factors. The increasing prevalence of antibiotic-resistant infections is a primary driver, necessitating more frequent and comprehensive testing. Government initiatives and regulations aimed at controlling the spread of resistance and improving antibiotic use are also contributing to market growth. Additionally, the growing demand for rapid and accurate diagnostic tools in healthcare settings has spurred the adoption of advanced AST methods. The expansion of clinical laboratories and the rising investment in research and development further support the market. These factors, combined with the ongoing need for effective infection control measures, ensure a strong growth trajectory for the antimicrobial susceptibility testing market.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Manual Antimicrobial Susceptibility Testing Products segment, which is expected to reach US$1.5 Billion by 2030 with a CAGR of a 3.7%. The Automated Laboratory Instruments segment is also set to grow at 3.0% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $970.2 Million in 2023, and China, forecasted to grow at an impressive 6.8% CAGR to reach $992.2 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Antimicrobial Susceptibility Testing Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Antimicrobial Susceptibility Testing Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Antimicrobial Susceptibility Testing Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Accelerate Diagnostics, Inc., Alifax S.r.l., Becton Dickinson, and Company, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 52 Featured):

  • Accelerate Diagnostics, Inc.
  • Alifax S.r.l.
  • Becton Dickinson, and Company
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Biotron Limited
  • Bruker Corp.
  • Creative Diagnostics
  • Danaher Corporation
  • ELITech Group
  • F. Hoffmann-La Roche AG
  • HiMedia Laboratories Pvt. Ltd.
  • Liofilchem S.r.l.
  • Mast Group Ltd.
  • Merck KGaA
  • MP Biomedicals LLC
  • Q-linea AB
  • QuantaMatrix, Inc.
  • Resistell AG
  • Thermo Fisher Scientific, Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Global Economic Update
  • An Introduction to Antimicrobial Susceptibility Testing
  • Antibiotic Sensitivity Testing Methods
  • Global Market Prospects & Outlook
  • Segment Analysis
  • Developed Regions Lead, Promising Growth in Store Across Developing Economies
  • Competition
  • Antimicrobial Susceptibility Testing - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Infectious Diseases & Overuse of Antibiotics Fuel Demand for Antimicrobial Susceptibility Testing
  • Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
  • Infectious Diseases Related Mortality High Among Children Below 5 Years: Breakdown of Leading Causes of Death in Children Below 5 Years (in %)
  • Rise in Prevalence of Respiratory Infections Drive Market Growth
  • Global Number of Deaths Caused Due to Communicable Diseases (In 000s)
  • Antimicrobial Susceptibility Testing Finds Growing Acceptance in Clinical Diagnostics
  • Growing Use of Antimicrobial Susceptibility Testing by Biopharma Companies Boosts Market Prospects
  • Increasing Need to Reduce Hospital Acquired Infections Presents Growth Opportunities
  • Leading Nosocomial Infections in the US: Percentage Breakdown of Healthcare Cost by Infection Type
  • Government Initiatives for the Detection & Control of Antimicrobial Resistant Species Augurs Well for the Market
  • AST to Play a Critical Part in Regulating Development of Antimicrobial Resistances
  • Introduction of Digital Technologies Streamlines Process Associated with Developing Vaccines
  • AST Technologies Helping Accelerate Targeted Antimicrobial Therapy
  • Antimicrobial Susceptibility Testing Plays Key Role in Medical Decision Making
  • rAST: Accelerating the Process of Antimicrobial Susceptibility Testing
  • Faster Antibiotic Susceptibility Tests Become Vital for High-Priority Pathogens
  • Digital Technologies Help in Rapid Antimicrobial Susceptibility Testing
  • Emerging AST Methods to Facilitate Wider Adoption
  • Rapidly Evolving Bacterial Pathogens and the Role of Rapid POC AST Diagnostics
  • Demand for Digital Medical Devices Bodes Well for the Market
  • Development of AST Standards to Enable Responsible Antimicrobials Usage
  • Antimicrobial Susceptibility Test Breakpoints
  • Advent of Innovative Technologies Foster Growth for Antimicrobial Susceptibility Testing Market
  • Use of Artificial Intelligence-Based Applications Exhibits a Surge
  • Novel Tools Focus on Antibiotic-Resistant Microbes
  • Researchers Develop Novel Methods to Acquire Outcomes on Susceptibility of Bacteria
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Antimicrobial Susceptibility Testing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Antimicrobial Susceptibility Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 3: World Historic Review for Antimicrobial Susceptibility Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 4: World 16-Year Perspective for Antimicrobial Susceptibility Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Manual Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 6: World Historic Review for Manual Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 7: World 16-Year Perspective for Manual Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Automated Laboratory Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 9: World Historic Review for Automated Laboratory Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 10: World 16-Year Perspective for Automated Laboratory Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Culture & Growth Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 12: World Historic Review for Culture & Growth Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 13: World 16-Year Perspective for Culture & Growth Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 15: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 16: World 16-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Antibacterial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 18: World Historic Review for Antibacterial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 19: World 16-Year Perspective for Antibacterial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Antifungal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 21: World Historic Review for Antifungal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 22: World 16-Year Perspective for Antifungal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Antiparasitic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 24: World Historic Review for Antiparasitic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 25: World 16-Year Perspective for Antiparasitic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 26: World Recent Past, Current & Future Analysis for Other Testing Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 27: World Historic Review for Other Testing Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 28: World 16-Year Perspective for Other Testing Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Antimicrobial Susceptibility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
CANADA
JAPAN
  • Antimicrobial Susceptibility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
CHINA
  • Antimicrobial Susceptibility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
EUROPE
  • Antimicrobial Susceptibility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
FRANCE
  • Antimicrobial Susceptibility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
GERMANY
  • Antimicrobial Susceptibility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
ITALY
UNITED KINGDOM
  • Antimicrobial Susceptibility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Antimicrobial Susceptibility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
AUSTRALIA
  • Antimicrobial Susceptibility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Antimicrobial Susceptibility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Antimicrobial Susceptibility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Antimicrobial Susceptibility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Antimicrobial Susceptibility Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned

  • Accelerate Diagnostics, Inc.
  • Alifax S.r.l.
  • Becton Dickinson, and Company
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Biotron Limited
  • Bruker Corp.
  • Creative Diagnostics
  • Danaher Corporation
  • ELITech Group
  • F. Hoffmann-La Roche AG
  • HiMedia Laboratories Pvt. Ltd.
  • Liofilchem S.r.l.
  • Mast Group Ltd.
  • Merck KGaA
  • MP Biomedicals LLC
  • Q-linea AB
  • QuantaMatrix, Inc.
  • Resistell AG
  • Thermo Fisher Scientific, Inc.

Table Information